Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

468
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
468
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

706
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
706

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher PRBC transfusion volume and frequency are associated with higher risk of moderate-to-severe bronchopulmonary dysplasia or mortality in extremely preterm infants: A retrospective cohort study.

Medicine·2026
Same author

An Edge On-Chip-Learning Convolutional Spiking Neural Network Processor Based on Error Backpropagation via Spatiotemporal Nodes of Spike Events.

IEEE transactions on biomedical circuits and systems·2026
Same author

Integrated transcriptomic and proteomic profiling in keloid tissue.

PeerJ·2026
Same author

Inhibitors of the Machupo Virus L Endonuclease for Bolivian Hemorrhagic Fever Treatments.

Microorganisms·2026
Same author

Targeting the gut-brain axis: probiotic intervention alleviates depressive-like behaviors and social deficit after cranial irradiation.

International immunopharmacology·2026
Same author

Autoantibodies combined with systemic inflammation markers for predicting bone metastases in non-small cell lung cancer patients.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jan 1, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K

Mild cognitive impairment understanding: an empirical study by data-driven approach.

Liyuan Liu1, Bingchen Yu1,2, Meng Han3

  • 1Data-driven Intelligence Research Laboratory, Kennesaw State University, 1100 South Marietta Pkwy, Marietta, GA, USA.

BMC Bioinformatics
|December 26, 2019
PubMed
Summary

Identifying modifiable risk factors is key to preventing mild cognitive impairment (MCI). This study reveals known and new factors, including lifestyle and chronic conditions, impacting cognitive decline.

Keywords:
Data-driven approachMachine learningMild cognitive deline impairment (MCI)

More Related Videos

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.5K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.7K

Related Experiment Videos

Last Updated: Jan 1, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.5K
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
06:58

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

7.7K

Area of Science:

  • Public Health
  • Gerontology
  • Epidemiology

Background:

  • Cognitive decline, including mild cognitive impairment (MCI), poses a significant public health challenge.
  • MCI can progress to dementia and Alzheimer's disease, necessitating preventative strategies.
  • Identifying and mitigating modifiable risk factors for MCI is a crucial public health objective.

Purpose of the Study:

  • To re-examine established risk factors for cognitive decline.
  • To identify novel risk factors contributing to mild cognitive impairment (MCI).
  • To apply data-driven methods and machine learning for risk factor analysis and prediction of cognitive decline.

Main Methods:

  • Utilized nationwide telephone survey data from the Centers for Disease Control and Prevention (CDC).
  • Employed a data-driven approach to analyze risk factors associated with cognitive decline.
  • Incorporated machine learning and deep learning algorithms to assess factor importance and predict cognitive decline.

Main Results:

  • Confirmed the importance of factors like depression, physical health, smoking, education, and sleep in cognitive decline.
  • Identified previously underexplored risk factors for MCI, including arthritis, pulmonary disease, stroke, asthma, and marital status.
  • Machine learning models were used to weigh the contribution of various factors to MCI risk.

Conclusions:

  • A data-driven approach effectively identifies significant disease risk factors.
  • The identified correlations between risk factors and MCI can potentially inform other medical diagnoses.
  • This research highlights the importance of a comprehensive approach to understanding and preventing cognitive decline.